Smart Insulin Pens and Pumps Strategic Analysis Report 2024: Global Market to Reach $9.2 Billion by 2030, Driven by Integration with Mobile Apps, AI-Powered Coaching, and Data Analytics - ResearchAndMarkets.com

The "Smart Insulin Pens and Pumps - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

The global market for Smart Insulin Pens and Pumps was estimated at US$5.2 Billion in 2023 and is projected to reach US$9.2 Billion by 2030, growing at a CAGR of 8.6% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Smart insulin pens and pumps are advanced medical devices designed to improve diabetes management by providing accurate, real-time data and personalized insulin delivery. Smart pens deliver insulin in measured doses, while smart pumps provide continuous subcutaneous insulin infusion based on the user`s glucose levels.

These devices offer features like Bluetooth connectivity, dose tracking, and integration with mobile apps, enabling users to monitor and adjust insulin usage with precision. By supporting personalized therapy and reducing the risk of complications, smart insulin pens and pumps are transforming diabetes care for both Type 1 and Type 2 diabetics.

What Factors Are Driving the Growth in the Smart Insulin Pens and Pumps Market?

The growth in the Smart Insulin Pens and Pumps market is driven by several factors, including increasing diabetes prevalence, which has heightened the need for more effective insulin management solutions. Advancements in device technology, such as improved connectivity, dose accuracy, and CGM integration, have enhanced user convenience and therapy outcomes.

The rising focus on personalized medicine and self-management in diabetes care has accelerated the adoption of smart insulin devices. Government initiatives promoting digital health and chronic disease management have further fueled demand, as patients seek advanced solutions to improve quality of life. Additionally, healthcare providers' focus on reducing hospital readmissions and improving patient outcomes has contributed to the widespread adoption of smart insulin pens and pumps.

What Are the Key Segments in the Smart Insulin Pens and Pumps Market?

Key product types include smart insulin pens, smart insulin pumps, and connected insulin caps, with smart insulin pumps holding the largest market share due to their continuous glucose monitoring (CGM) compatibility and ability to automate insulin delivery. Major applications cover Type 1 and Type 2 diabetes, with Type 1 diabetes representing a significant segment as these patients require consistent insulin management. End-users include hospitals, clinics, and home care, with home care leading the market due to the increasing adoption of self-management tools by diabetic patients.

How Are Smart Insulin Devices Integrated Across Diabetes Care?

Smart insulin pens are equipped with dose memory, dose recommendations, and missed dose alerts, helping users manage mealtime and correction insulin effectively. Smart pumps, often integrated with continuous glucose monitoring (CGM) systems, automatically adjust insulin delivery based on glucose readings, supporting stable blood sugar levels. In hospitals and clinics, these devices are used to improve insulin therapy outcomes, reduce errors, and provide real-time data to healthcare professionals for patient monitoring.

Additionally, home care patients use mobile apps linked to smart pens and pumps to track insulin usage, review glucose trends, and receive personalized therapy adjustments, supporting better self-care and adherence.

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of major players in the Global Smart Insulin Pens and Pumps Market such as Cellenovo, Companion Medical Inc., Emperra Gmbh E-Health Technologies, F Hoffmann-La Roche, Insulet Corporation and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Smart Insulin Pumps segment, which is expected to reach US$7.9 Billion by 2030 with a CAGR of a 8.1%. The Smart Insulin Pens segment is also set to grow at 12.7% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, estimated at $1.4 Billion in 2023, and China, forecasted to grow at an impressive 8.2% CAGR to reach $1.4 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Key Attributes:

Key Topics Covered:

MARKET OVERVIEW

• Influencer Market Insights
• World Market Trajectories
• Global Economic Update
• Smart Insulin Pens and Pumps - Global Key Competitors Percentage Market Share in 2024 (E)
• Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)

MARKET TRENDS & DRIVERS

• Rising Prevalence of Diabetes Spurs Demand for Smart Insulin Pens and Pumps
• Technological Advancements in Real-Time Glucose Monitoring and Automated Insulin Delivery Drive Adoption
• Growing Focus on Personalized Diabetes Management Expands Addressable Market for Smart Insulin Devices
• Expansion of Smart Insulin Solutions in Home Healthcare and Remote Patient Monitoring Fuels Market Growth
• Increasing Demand for Accurate Dosing, Safety Alerts, and Predictive Analytics Drives Adoption
• Integration with Mobile Apps, AI-Powered Coaching, and Data Analytics Strengthens Business Case
• Rising Focus on Patient Adherence, Dosage Tracking, and Data-Driven Insights Accelerates Demand
• Technological Innovations in Needle-Free Insulin Delivery and Wearable Infusion Pumps Propel Market Growth
• Growing Use of Smart Insulin Devices in Pediatrics, Geriatrics, and Special Populations Drives Adoption
• Focus on Achieving Seamless Integration with Telehealth Platforms Expands Addressable Market
• Technological Advancements in Long-Lasting Battery, Compact Design, and Bluetooth Connectivity Propel Growth
• Rising Demand for Cost-Effective, Reusable, and Disposable Smart Insulin Devices Generates Market Opportunities

FOCUS ON SELECT PLAYERS: Some of the 33 companies featured in this report include

• Cellenovo
• Companion Medical Inc.
• Emperra Gmbh E-Health Technologies
• F Hoffmann-La Roche
• Insulet Corporation
• Jiangasu Delfu Medical Device Co Ltd
• Medical Inc.
• Medtronic Inc.
• Novo Nordisk
• Sooil Development
• Tandem Diabetes Care
• Valeritas Inc.
• Ypsomed

For more information about this report visit https://www.researchandmarkets.com/r/uou2ib

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250130145784/en/